Clinical value of early enteral nutrition through Freka Trelumina in treatment of patients with hilar cholangiocarcinoma

Abstract

Objective To analyze the clinical value of early enteral nutrition through Freka Trelumina in the treatment of patients with hilar cholangiocarcinoma after radical surgery.Methods 42 patients with hilar cholangiocarcinoma treated at our hospital from June,2012 to June,2014 were selected as study objects and were divided into an ordinary tube group and a Freka Trelumina group according to their admission times.After the operation,both groups took the same enteral nutrition.The anal exhaustion time,diarrhea,vomiting,nausea,incision infection,abdominal infection,lung infection,and drainage volume of gastric juice and the clinical indicators of liver and kidney functions 8 days after operation were analyzed and compared between these two groups.Results The pulmonary infection rate was 7.0％ in the ordinary tube group and was 1％ in the Freka Trelumina group,with a statistical difference (P ＜ 0.05).The incidence nausea and vomiting rate was 3.0％ in the Freka Trelumina group and was 12.0％ in the ordinary tube group,with a statistical difference (P ＜ 0.05).igher than the ordinary tube group were low (P ＜ 0.05).There were no statistical differences in the anal exhaustion time,the drainage volume of gastric juice,time,incision infection rate,abdominal infection rate,etc.between these two groups (P ＞ 0.05).8 days after operation,the bilirubin content significantly decreased,the liver function was restored,and the renal function recover to normal in both groups,with no statistical differences (P ＞ 0.05).Conclusions Early enteral nutrition through Freka Trelumina in the treatment of patients with hilar cholangiocarcinoma after radical surgery is safe,reliable and well tolerated and can reduce the incidence of postoperative complications.